Inpharmation Ltd. commits to reduce absolute scope 1 and scope 2 GHG emissions 42% by 2030 from a 2024 base year, and to measure and reduce its scope 3 emissions.
The SBTi has approved Inpharmation Ltd’s near-term science-based emissions reduction target.
Click here to read our commitment published on the SBTi website.